Fem-Flax

banner_main
Fem-Flax
® Product Description

Fem-Flax is a concentrated, all-natural plant food supplement that has been specially formulated treatment to help relive menopause symptoms, specifically, hot flashes, night sweats, mood swings, etc.

The concentrated active ingredient in Fem-Flax has been clinically tested and has been shown to totally eliminate or lessen the severity of these symptoms.  In addition to being safe and effective, every batch of Fem-Flax has been laboratory analyzed to insure that it meets our rigid potency standards.

Fem-Flax has been encapsulated for ease and convenience and each bottle contains 180 capsules, each packed with 700mg of concentrated, active ingredients.  Fem-Flax contains no fillers, additives, or preservatives and yet, boasts a minimum shelf life of at least 4 years, without a reduction in potency.

We are so confident that Fem-Flax will help to relieve your symptoms that Fem-Flax offers a full, money-back guarantee should you not be satisfied with the effectiveness of this product*.

There should be enough product packed in every bottle of Fem-Flax to provide even the chronic sufferer a measure of relief for 30 days.

We hope that you will try Fem-Flax soon so that you can begin experiencing the relief that so many women can already attest to. 

  • Fast Delivery
  • Multiple shipping methods to choose from
  • Use your favorite credit card or Pay Pal
  • Most orders received prior to 2:00PM CST ship same day
  • Bottle is double safety sealed for your protection
  • Each bottle ships in its own custom shipper

*Money Back Satisfaction Guarantee: If you are dissatisfied with the effectiveness of our product and return the unused portion, you will receive a full refund of the amount charged at invoice, less shipping cost. [click here] for full details.
flax hull lignans

Concentrated Fem-Flax® 180 capsules bottle
$34.95

Fem-Flax® and Prostate Cancer

Prostate cancer develops primarily in men over fifty and is the leading cause of cancer death in U.S. men after lung cancer.

Some pharmaceutical drugs like Finasteride formerly thought to reduce the incidence of prostate cancer, actually inhibit the early detection of prostate cancer cells.  In fact the June, 2008 edition of The Medical Letter states; “Finasteride might cause more aggressive (prostate) tumors.”  The article concludes: "Until more evidence becomes available, the conservative course would be not to take it."

According to the study, Finasteride has also been associated with erectile dysfunction and a lower sex drive.

If pharmacological drug treatments are questionable, what other preventative treatments are available?

As early as 70 years ago, researchers have been investigating the chemical properties of estrogens and phytoestrogens in an effort to thwart prostate cancer growth.

In 1941, Charles B. Huggins published studies in which he used estrogen to oppose testosterone production in men with metastatic prostate cancer. This discovery eventually won Huggins the 1966 Nobel Prize in Physiology or Medicine.

More recently, phytoestrogens found in plant lignans have been found to be effective antagonists against prostate cancer cell proliferation and first-time formation.

In the entire plant kingdom, phytoestrogens from flax hull lignans represent the greatest source of phytonutrient bioavailability.

How do Phytoestrogens Work to Stop the Growth of Prostate Cancer Cells?

Metabolized phytoestrogens (in this case, enterolactone) bind to the same receptor sites on cells as estrogen. This action can prevent hormones from binding to cells on hormone-dependent cancerous prostate tumors.  In effect, slowing prostate tumor growth or prohibiting prostate cancer cell growth in the first place.

Once metabolized, flax hull lignans are converted to the enterolignans enerodiol and enterolactone.

“The enterolignans, enterodiol and enterolactone, are formed by the action of intestinal bacteria on lignan precursors found in (flax) plants. Because enterodiol and enterolactone can mimic… the effects of estrogens, their plant-derived precursors are classified as phytoestrogens.” December 2005, Jane Higdon, Ph.D., Linus Pauling Institute, Oregon State University

The mammalian lignan enterolactone is a major metabolite of plant-based lignans that has been shown to inhibit the growth and development of prostate cancer.

“Enterolactone selectively suppresses the growth of LNCaP prostate cancer cells by triggering apoptosis.  Our findings encourage further studies of enterolactone as a promising chemopreventive agent against prostate cancer.” [Mol Cancer Ther 2007;6(9):2581–90]

“Enterolactone, a major metabolite of plant-based lignans, has been shown to inhibit prostate cancer growth and development. Enterolactone suppresses proliferation and migration of prostate cancer cells.  The finding of this study provides new insights into the molecular mechanisms that enterolactone exerts against prostate cancer.” J. Nutr. April 2009 vol. 139 no. 4 653-659

Encapsulated Fem-Flax contains the highest concentration of all-natural plant-based phytonutrients available on the market today.  To learn more about cancer prevention and the disease inhibiting capabilities of Fem-Flax, please see our website at: www.femflax.com.

Fem-Flax® and Hysterectomy

“Phytoestrogens, compounds derived from plants and converted into weak estrogenic substances in the gastrointestinal tract, are heavily promoted as the “natural alternative” to estrogen replacement therapy for postmenopausal women or women who have undergone a hysterectomy.” Western Journal of Medicine v.173 (4); Oct 2000.

The outer cover of the flaxseed (hull) offers the richest supply of naturally occurring plant-based lignans and the most potent source of phytoestrogens in the entire plant kingdom.  These naturally occurring plant compounds are similar in some ways to estradiol, the most powerful and prevalent of the three naturally occurring hormones produced by the ovaries.

Unlike estrogen, the phytoestrogens in Fem-Flax do not increase the risk of breast or uterine cancer. While balancing hormones on the one hand, in vivo clinical studies have shown that the powerful lignans in Fem-Flax also have an anti-estrogenic effect and actually help to prohibit the first time and potential regrowth of breast cancer cells, as well as other tumorous growths.

Studies show that these phytoestrogens act more like SERMS (selective estrogen receptor modulators) than actual estrogens.

Fem-Flax can act as a safe and effective menopause symptom management tool and can be used by pre, peri, and postmenopausal women, women having undergone full or partial hysterectomies, or women searching for a safe alternative to HRT (hormone replacement therapy).

Fem-Flax® and Lung Cancer

A new deterrent in the fight against lung cancer has been discovered.  Lung cancer is still the leading cause of cancer related deaths among men and women living in the United States.  According to a study published in the Journal of the American Medical Association, consuming foods rich in phytoestrogens appears to significantly lower the risk of developing lung cancer in smokers and non-smokers (but not previous smokers).

 The study, the largest of its kind to examine dietary intake of phytoestrogens and lung cancer risk in the United States, involved over 3,500 people. The American Cancer Society's most recent estimates for lung cancer in the United States are for 2010:

 * About 222,520 new cases of lung cancer will be diagnosed (116,750 among men and 105,770 among women).

* There will be an estimated 157,300 deaths from lung cancer (86,220 among men and 71,080 among women), accounting for about 28% of all cancer deaths.

Lung cancer is by far the leading cause of cancer death among both men and women. More people die of lung cancer than of colon, breast, and prostate cancers combined.

Lung cancer mainly occurs in older people. About 2 out of 3 people diagnosed with lung cancer are older than 65; fewer than 3% of all cases are found in people younger than 45. The average age at the time of diagnosis is about 71.

Overall, the chance that a man will develop lung cancer in his lifetime is about 1 in 13; for a woman, the risk is about 1 in 16. These numbers include both smokers and non-smokers. For smokers the risk is much higher, while for non-smokers the risk is lower.

Black men are about 40% more likely to develop lung cancer than white men. The rate is about the same in black women and in white women. Both black and white women have lower rates than men, but the gap is closing. The rate of lung cancer has been dropping among men for many years and is fairly stable among women.

How Phytoestrogens Work

During the test, certain whole foods were introduced into the diet of test subjects to determine the potential antigen effect of phytoestrogens from plant lignans and flavonoids on lung cancer cell growth and proliferation.  Those foods producing a higher ratio of phytonutrients were deemed to be the most effective.  A surprising 72% lowered risk of developing lung cancer was achieved by individual test subjects consuming whole foods containing the highest concentration of phytonutrients.

"What we have found is intriguing and supports a small but growing body of evidence that suggests estrogenic-like compounds in food may help protect against development of lung and other cancers," says Matthew Schabath, PhD, a postdoctoral researcher in the Department of Epidemiology and the study's lead author.

While phytoestrogen-rich whole foods are certainly a boon to those concerned about cancer risks, they do not represent the most potent source of phytoestrogens.  Concentrated flax hull lignans can offer ten-times the phytoestrogenic potency of whole grain flaxseed and are potentially hundreds of times more potent than other whole foods containing phytonutrients.

Once metabolized, flax hull lignans are converted to the enterolignans enerodiol and enterolactone.

“The enterolignans, enterodiol and enterolactone, are formed by the action of intestinal bacteria on lignan precursors found in (flax) plants. Because enterodiol and enterolactone can mimic… the effects of estrogens, their plant-derived precursors are classified as phytoestrogens.” December 2005, Jane Higdon, Ph.D., Linus Pauling Institute, Oregon State University.

The study indicated that a “high intake of the lignans enterolactone and enterodiol… were associated with a (significant) reduction in risk of lung cancer.” Phytoestrogens and Risk of Lung Cancer -  Peter C. H. Hollman, Ivon E. J. Milder, Ilja C. W. Arts, Edith J. M. Feskens, H. Bas Bueno de Mesquita,  Daan Kromhout, JAMA. 2006;295(7):755.doi:10.1001/jama.295.7.755-a

Encapsulated Fem-Flax® offers the highest concentration of lignin-rich phytoestrogens on the market today (700mg, 99% pure flax hull lignans per capsule with 60 to 70mg of SDG lignan -  Secoisolariciresinol Diglucoside).  Fem-Flax offers the full-spectrum of 27 lignan bioavailability.

If cancer risk is a concern, please consider adding Fem-Flax to your daily health regimen.  For more information on the cancer-fighting properties of the phytonutrients contained in Fem-Flax, please consult our website at: www.femflax.com.

About Fem-Flax®

Concentrated Fem-Flax has been especially formulated for women of menopausal age in an effort to combat “hot flashes” and “night sweats”, symptoms traditionally associated with menopause.

The active ingredients in Fem-Flax are commonly referred to as “flax hull lignans”.  Each Fem-Flax capsule contains 99.9% of the full-spectrum of 27 available flax hull lignans.  Fem-Flax contains no additives, fillers, preservatives or other unnecessary inert compounds. Each capsule is packed end to end, with highly concentrated all-natural active ingredients (700mg).

Fem-Flax, made from the outer portion of the flax hull, is much better at reducing menopause symptoms than either whole ground flaxseed, flasxeed oil, ect.  Fem-Flax is a concentrated powder made from the outer area of the seed hull. The oily embrio portion of the seed is not used in this product.

In that the active ingredient affecting menopause symptoms is only found in the seed hull (about 18% by weight of the entire whole seed), Fem-Flax becomes highly concentrated and far less product needs to be taken to be effective.

A daily regimen of Fem-Flax is much different than eating whole ground flaxseed. In order to obtain the same potent lignan count found in concentrated Fem-Flax, you would have to ingest many more times the volume in whole ground flaxseed.

The ‘active’ mammalian lignans produced in the body with flaxseed consumption have hormonal effects in women and help to relieve menopausal symptoms such as hot flashes and night sweats. These act by binding to estrogen receptors on cell membranes.

Most realize that during menopause, the levels of endogenous (naturally occurring) estrogens in the blood decrease naturally because the ovaries produce and release fewer natural estrogens.

While mammalian lignans may not be as powerful as natural estrogens, the complete full-spectrum of 27 lignans found in FemFlax have been clinically proven to be as effective as ‘hormone replacement therapy’ in improving menopause symptoms.

The good news is that the concentrated flax hull lignans found in Fem-Flax act as weak estrogen replacements, and in this way, help to alleviate the hot flash and night sweats symptoms associated with menopause.

The Difference Between Fem-Flax® and Whole Ground Flaxseed

whole_ground_flaxseed

In 2007 the Mayo Clinic conducted a double-blind study on women of menopausal age to determine the effects of whole ground flaxseed on common menopause symptoms like hot flashes, night sweats, irritability, etc.

Each woman consumed 40 grams daily (8 teaspoons) of whole ground flaxseed. Notably, of the women who were able to finish the test, a 57% reduction in symptoms was realized.

Unfortunately, only about half of the women taking flaxseed (not the placebo) were able to finish the test.  The other half fell out of the test (some as early as one of two days) due to problems with diarrhea and other digestive difficulties.

While the average American diet is severely lacking in fiber, whole ground flaxseed is very high in soluble and non-soluble fiber.  Easily half of the women in the Mayo Clinic test could not tolerate 8 teaspoons (of whole ground flaxseed) per day and were forced to drop out early.

Why 8 teaspoons per day?

The non-placebo recipients during the testing phase where given unadulterated whole ground flaxseed.  The dose was determined so that the active phytonutrients in flaxseed would have a chance to produce the desired results.

Later studies revealed ways in which the active ingredients could be isolated, thus reducing the dose requirements by volume and weight.  This reduction process allowed a much more potent dose while at the same time, eliminating the risk of ingesting too much fiber.

The active ingredients in flaxseed come from the outer hull portion of the seed (18% of total seed weight) and not the larger, oily embryo portion of the seed. These are called “lignans”.  These flax hull lignans produce a weak phytoestrogenic effect and once metabolized, have the unique capacity to attach themselves to estrogen receptor cells within the body.

While not as potent as real female estrogens (estradiol), taken in sufficient quantity, they can produce the same ameliorating effects as real female hormones.

As realized in the 2007 study, the problem comes in providing a strong enough dose (to be effective), without (at the same time) producing digestive concerns.

Flax Hull Lignans

Researchers soon found a number of ways to isolate the hard outer covering from the embryo portion of the seed. Various methods were tried including water baths, steam baths, acetate baths, or various combinations of these in an attempt to successfully loosen the hull from the seed, making separation easier.

However, some researchers determined that the introduction of any liquid (during the separation process) could reduce the shelf-life or the phytonutrient bioavailability of the finished product, or allow the development of mold or other bacteria.

Fem-Flax uses a patented dry, cold-press process which exacts pressures of 10,000 lbs. per square inch to separate the flax hull lignans.  Further refinement reduces the product to a fine powder which is encapsulated into individual gel-caps containing 700mg of 99.9% pure flax hull lignans, each.

The recommended dose of Fem-Flax (6 capsules per day) only equates to 4.2 grams of product, less than a single teaspoon (5 grams) but offers more potency than the 8 teaspoons per day (of whole ground flaxseed) given to the Mayo Clinic test subjects, and with near-zero risk of problematic digestive side-effects.

Encapsulated Fem-Flax is easy to take and provides accurate dosage delivery without measuring.  In addition to the digestive risks, a daily regimen of whole ground flaxseed can be a messy proposition and/or cause unnecessary weight gain.

Mixed into water, whole ground flaxseed has a tendency to stick to the sides of the glass and clump to the bottom, making it nearly impossible to consume the entire dose.  Also, 8 teaspoons of whole ground flaxseed would require several glasses of water.

To offset this approach, some manufacturers contend that whole ground flaxseed can be toasted and added as a topping to either ice cream or yogurt.  Other suggestions call for adding small amounts of whole ground flaxseed (as an ingredient) to baked muffins or bread.  This “add to other food solution” quickly begs the question; “Using these methods, how much ice cream, yogurt, muffins, or bread slices would be necessary per day to deliver 40 grams of whole ground flaxseed?”

You can see that the “added to food” delivery method is totally ineffectual and can quickly add unnecessary and unwarranted calories and carbohydrates to the daily diet and this, at a time in life when most women have added concerns about weight gain. Also, this method does not take into account the additional food cost and preparation time required.

The other but usually unmentioned concern is flavor.  Frankly and in our opinion, whole ground flaxseed does not taste very good.  By comparison, wheat germ is a culinary delight.  One of our competitors even adds vanilla and MSG to their encapsulated product to help mask any off-putting flavors.

Another disadvantage and concern related to any whole ground flaxseed product, is longevity or shelf-life.  Whole ground flaxseed will quickly degrade and become rancid within days or weeks, even with refrigeration. This is due to the high oil content of whole ground flaxseed.  Once the container is opened, whole ground flaxseed should not be exposed to air or light.

Due to the unique and patented production process, Fem-Flax remains entirely dry, potent, and stable (even without refrigeration) for four years or more.  Again, it must be remembered that Fem-Flax is 99.9% pure flax hull lignans produced from the dry outer hull covering (where all of the phytonutrients are contained) and not the oily embryo seed portion.

Encapsulated Fem-Flax offers the safest, most potent, and accurate of all flax hull lignan delivery methods on the market today. At just $34.95 (for a one-month supply), it is also one of the least expensive.

hot_flashes

Why encapsulated Fem-Flax®?

Regardless of diet and exercise, the female body goes through a number of changes over the years, and as the years unfold, many women find it increasingly difficult to shed unwanted pounds.

Sufficient scientific evidence is available to support the notion that hormonal changes and declining estrogen levels in advancing years can be a catalyst for weight gain.

Whether you’re counting calories or carbohydrates, the good news about Fem-Flax is that it contains few calories and  carbohydrates!

All natural encapsulated Fem-Flax® can be taken directly with water, unlike other powdered flax hull products which must be sprinkled on, or mixed into food as an additive.

Beyond the question of unwanted calories and carbohydrates, there is no need to prepare additional meals, snacks, smoothies, etc., as part of your Fem-Flax regimen.

Concentrated Fem-Flax capsules provide the hot-flash/night-sweat stopping power you need, without the concern of additional and unwanted calories and carbohydrates.

Flaxseed and Heart Disease

Persons of all ages, socioeconomic, and cultural backgrounds can develop heart disease and it is the leading cause of death in the U.S.

Heart disease contributed to 26% of the deaths in 2006 in the United States, about 1 in 4 or 206,636 persons.

While heart disease was considered to be a mostly male problem a quarter century ago, today half the deaths attributed to heart disease were women.  HD is the leading cause of death (in the U.S.) for both men and women.

The leading type of heart disease is coronary artery disease and in 2005 445,687 persons, both men and women died from this type of heart disease.

Currently, 785,000 American annually suffer their first heart attack.  Almost an equal number who have already suffered one or more attacks, have another attack.

This year heart disease will cost the U.S. $316.4 Billion dollars in the cost of health care services, medications, and lost productivity.

Health care professionals frequently propose invasive surgical procedures as a potential means of extending the longevity of heart patients.  Obviously, these procedures usually follow the failure of diet changes, exercise, and prescription drugs for high blood pressure and elevated cholesterol.

In addition to radical changes in diet and exercise and more closely monitored blood pressure and cholesterol levels, health care professionals routinely advocate much more invasive surgical procedures as a means of (potentially) extending the lives of heart disease patients.

The more common procedures include heart bypass surgery, heart valve reconstruction, angioplasty, stenting, coronary artery bypass, cardiac catheterization, and transmyocardial revascularization.

In recent years the success rate of these (first time) procedures is relatively high, at 92% - 95%.  However, the extended life-expectancy following heart surgery is at best, about the same as the average life-expectancy of someone without heart disease.

Several factors come into play when attempting to calculate surgery survival rates and longevity following surgery.  Males seem to perform better than females (due to the simple fact that their arteries are larger and easier to bypass), and younger people in the target age group 50-55 have lower mortality rates as compared to older persons over 75.

As a point of interest it must be noted that these surgical procedures do nothing to resolve the underlying cause of the disease.  As a result, patients will frequently be forced to endure the same surgery again and again, often within 5 to 7 years of the initial operation.  Succeeding procedures statically do not prove to have as high a success rate as the initial surgery.

Perhaps due to these facts and the extremely high costs inherent with these procedures, some health care professionals are beginning to suggest that many of the aforementioned surgical procedures are unnecessary and that non-invasive techniques perform just as well at a fraction the cost.

In spite of the costs, Americans have historically led the world in opting for the more invasive and immediate treatment plans.  The reasons for this difference is likely due (historically) to inexpensive employer provided health care, inactive life-styles, lack of sufficient daily exercise, poor eating habits, and the desire for a quick fix rather than life-style overhaul.

Americans opt for surgery as the first choice 4 to 1 over their Canadian and European counterparts, though heart disease is nearly as rampant in these geographical regions.

Again, the numbers seem to indicate that Americans want to take more immediate action rather than making (relatively) slow changes to diet and exercise to achieve similar health results.

The reason for continued escalating health-care costs (in the U.S.) are directly attributable heart disease.

Unfortunately, due to the recent economic down turn, many Americans no longer have health care support of any kind.

As a result of this and other determining factors, Americans are beginning to more aggressively research the availability of alternative safe, effective, and economically viable heart disease treatment plans.

A recent study reported in the “Journal of Cardiovascular Pharmacology” (November, 2009) conducted at The Department of Physiology, University of Saskatchewan, Saskatoon, Canada, concluded that “flaxseed and its components improve Cardiovascular health”, and that flax hull lignans containing quantities “SDG  (secoisolariciresinol diglucoside) (the prominent phytoestrogen found in flax hull lignans) reduce the development of hypercholesterolemic atherosclerosis (coronary artery disease associated with elevated cholesterol levels).”

In vivo studies have shown that the “SDG (lignan) is a very potent hypotensive (anti-high blood pressure), angiogenic (formation of new blood vessels), and antiapoptotic (prevents cell death and degeneration) agent” and has an important “role in cardio-protection in ischemic (constriction or obstruction of the blood vessels surrounding the heart) heart disease.

“Lignans in general reduce serum total cholesterol and low-density lipoprotein cholesterol and raises serum high-density lipoprotein cholesterol” and “SDG” lignan “and its metabolites have antioxidant activity.”

FemFlax® is a concentrated and encapsulated (27 full-spectrum) flax hull lignan product and has one of the highest concentrations of SDG lignan bioavailability of any similar product on the market.